Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Travis W Bainbridge

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Scientific Reports|December 21, 2016
Structure of Crenezumab Complex with Aβ Shows Loss of β-HairpinMark Ultsch, Bing Li, Till Maurer, et al.
Cancer Discovery|November 9, 2019
Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15<sup>+</sup> Myofibroblasts as a Determinant of Patient Response to Cancer ImmunotherapyClaudia X Dominguez, Sören Müller, Shilpa Keerthivasan, et al.
Plos One|July 17, 2014
Evolutionary divergence in the catalytic activity of the CAM-1, ROR1 and ROR2 kinase domainsTravis W Bainbridge, Venita I DeAlmeida, Anita Izrael-Tomasevic, et al.
Science Immunology|May 8, 2021
IL-1R1-dependent signaling coordinates epithelial regeneration in response to intestinal damageChristian B Cox, Elaine E Storm, Varun N Kapoor, et al.
Frontiers in Immunology|February 28, 2025
A single point mutation on FLT3L-Fc protein increases the risk of immunogenicityDan Qin, Qui Phung, Patrick Wu, et al.
The Journal of Biological Chemistry|January 13, 2017
Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in MiceMegan Lo, Hok Seon Kim, Raymond K Tong, et al.
Journal for Immunotherapy of Cancer|July 15, 2025
Engineered IL-18 variants with half-life extension and improved stability for cancer immunotherapyTravis W Bainbridge, Lifen Wang, Marina Moskalenko, et al.
Scientific Reports|June 22, 2019
Adaptive adipose tissue stromal plasticity in response to cold stress and antibody-based metabolic therapyJoshua C Chang, Steffen Durinck, Mark Z Chen, et al.
Ebiomedicine|July 6, 2025
Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinationsJérémie Decalf, Evangeline Toy, Dongping He, et al.
Ebiomedicine|August 20, 2015
Sustained Brown Fat Stimulation and Insulin Sensitization by a Humanized Bispecific Antibody Agonist for Fibroblast Growth Factor Receptor 1/βKlotho ComplexGanesh Kolumam, Mark Z Chen, Raymond Tong, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Scientific Reports|December 21, 2016
Structure of Crenezumab Complex with Aβ Shows Loss of β-HairpinMark Ultsch, Bing Li, Till Maurer, et al.
Cancer Discovery|November 9, 2019
Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15<sup>+</sup> Myofibroblasts as a Determinant of Patient Response to Cancer ImmunotherapyClaudia X Dominguez, Sören Müller, Shilpa Keerthivasan, et al.
Plos One|July 17, 2014
Evolutionary divergence in the catalytic activity of the CAM-1, ROR1 and ROR2 kinase domainsTravis W Bainbridge, Venita I DeAlmeida, Anita Izrael-Tomasevic, et al.
Science Immunology|May 8, 2021
IL-1R1-dependent signaling coordinates epithelial regeneration in response to intestinal damageChristian B Cox, Elaine E Storm, Varun N Kapoor, et al.
Frontiers in Immunology|February 28, 2025
A single point mutation on FLT3L-Fc protein increases the risk of immunogenicityDan Qin, Qui Phung, Patrick Wu, et al.
The Journal of Biological Chemistry|January 13, 2017
Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in MiceMegan Lo, Hok Seon Kim, Raymond K Tong, et al.
Journal for Immunotherapy of Cancer|July 15, 2025
Engineered IL-18 variants with half-life extension and improved stability for cancer immunotherapyTravis W Bainbridge, Lifen Wang, Marina Moskalenko, et al.
Scientific Reports|June 22, 2019
Adaptive adipose tissue stromal plasticity in response to cold stress and antibody-based metabolic therapyJoshua C Chang, Steffen Durinck, Mark Z Chen, et al.
Ebiomedicine|July 6, 2025
Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinationsJérémie Decalf, Evangeline Toy, Dongping He, et al.
Ebiomedicine|August 20, 2015
Sustained Brown Fat Stimulation and Insulin Sensitization by a Humanized Bispecific Antibody Agonist for Fibroblast Growth Factor Receptor 1/βKlotho ComplexGanesh Kolumam, Mark Z Chen, Raymond Tong, et al.
Pageof 3